Want to take quizzes and track your credits?
We previously reported a substantial decline in new cancer diagnosed early in the COVID-19 pandemic in the United States. During the period from March 1 to April 18, 2020, weekly cases fell 46.4% (from 4310 to 2310) for 6 cancers combined, with significant declines for each type.1 This was expected, given recommendations to conserve health care resources to address the initial set of patients with COVID-19. Medical practices have since reopened, but patient concerns remain. This study updates the analysis through March 2021.
Sign in to take quiz and track your certificates
Accepted for Publication: July 13, 2021.
Published: August 31, 2021. doi:10.1001/jamanetworkopen.2021.25681
Open Access: This is an open access article distributed under the terms of the CC-BY-NC-ND License. © 2021 Kaufman HW et al. JAMA Network Open.
Corresponding Author: Harvey W. Kaufman, MD, Quest Diagnostics, 500 Plaza Dr, Secaucus, NJ 07094 (email@example.com).
Author Contributions: Dr Kaufman and Ms Chen had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: All authors.
Acquisition, analysis, or interpretation of data: Kaufman, Chen, Niles.
Drafting of the manuscript: Kaufman, Chen.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Chen, Niles.
Administrative, technical, or material support: Kaufman, Fesko.
Conflict of Interest Disclosures: Drs Kaufman and Fesko and Ms Chen reported owning stock in Quest Diagnostics outside the submitted work. No other disclosures were reported.
Additional Contributions: We appreciate the superb editorial support from Jeff Radcliff (Quest Diagnostics). He was not compensated beyond his usual salary.
You currently have no searches saved.